Tumor cells exhibit metabolic abnormalities to meet the elevated energy and biosynthetic demands associated with rapid tumor growth (12), and thus SOAT1 has become an essential target of metabolic therapy for tumor treatment. Here, SOAT1 is linked to neoplasm.